Advocacy Hub

  • All
  • GFF Update
  • Post-2015 Update
Toolkit: Advancing Women Leaders in Africa

ACCESS THE POLICY TOOLKIT

In March 2017, Her Excellency Dr. Joyce Banda, former President of Malawi and Founder of the Joyce Banda Foundation, launched her paper, “From Day One: An Agenda for Advancing Women Leaders in Africa” as the crux of her research while serving as a Distinguished Fellow at the Woodrow Wilson Center. To achieve this end, Dr. Banda published “From Day One: An Agenda for Advancing Women in Africa” which details the history of women’s leadership in Africa and some of the challenges and opportunities women face on their leadership journey. The paper includes five key recommendations for promoting women’s leadership in Africa:

1) Enhance political will to empower girls, and appoint qualified women to leadership positions

2) Mobilize rural leadership, families, and communities to promote the change of mindsets and behavior around women and girls

3) Strengthen networks between current and emerging leaders

4) Allocate resources towards data collection and analysis, and research around women and leadership

5) Create the legal environment to advance women in positions of leadership

In the second phase of her research, Dr. Banda spearheaded the creation of a toolkit to provide actionable steps to implement the recommendations.

The Changing Demographics of Global Health

Analysis of rapid rise of cancers, diabetes, cardiovascular diseases, and other noncommunicable diseases (NCDs) in poorer nations, and the preparedness of those nations’ health systems for that shift. Infographic courtesy: Council on Foreign Relations

 

In support of the Health Affairs study (see below), Michael R. Bloomberg, the World Health Organization’s Global Ambassador for Noncommunicable Diseases, issued the following quote:  

NCDs pose a major global health challenge, and these new findings underscore how important it is to confront them head-on. If we don’t act now, NCD risks will only continue to rise across low- and middle-income countries, threatening the livelihoods of current and future generations.”

The Council of Foreign Relations website now includes an engaging data interactive entitled the “Changing Demographics of Global Health.” This interactive resource was released in conjunction with a Health Affairs article that was released on November 2, 2017. The paper, “Lower-Income Countries That Face The Most Rapid Shift In Noncommunicable Disease Burden Are Also The Least Prepared,” analyzes the rapid rise of cancers, diabetes, cardiovascular diseases, and other noncommunicable diseases (NCDs) in poorer nations, and the preparedness of those nations’ health systems for that shift.

 

PATH Center for Malaria Control and Elimination (CMCE) launches “A Conceptual Framework for Malaria Elimination”

The PATH Center for Malaria Control and Elimination (CMCE) launched A Conceptual Framework for Malaria Elimination, a new report in the PATH Malaria Learning Series.

Building directly upon the WHO Elimination Framework, the report describes the steps to elimination as a practical approach for national malaria programs as they move along the continuum of decreasing malaria transmission intensity. These steps aim to help program managers and team members think about how to best deploy the tools at their disposal according to their country’s malaria transmission strata (from high to very low) and varying ecologic, epidemiologic, and societal features.

GHTC Releases New Global Health R&D Introductory Fact Sheet Series

GHC member GHTC released a new four-part introductory fact sheet series about the importance of global health research and development (R&D). The series explores why global health R&D is vital to achieving a healthier world, the historical gains achieved, and the health, security, and economic returns from investing in global health R&D.

View the fact sheet series here:

WHO WE ARE: GLOBAL HEALTH TECHNOLOGIES COALITION

WHY DOES GLOBAL HEALTH R&D MATTER?

WHAT HAS GLOBAL HEALTH R&D ACHIEVED?

WHY IS GLOBAL HEALTH R&D A SMART INVESTMENT FOR AMERICA?

Additionally, GHTC also released another fact sheet series examining how US government agencies contribute to global health R&D. Each fact sheet explores how the agency engages in global health R&D, the distribution of the agency’s R&D investments across health areas, and the impact generated by its work, including examples of R&D success stories.

United States Agency for International Development (USAID) Fact Sheet

National Institute of Health (NIH) Fact Sheet

The US Centers for Disease Control and Prevention (CDC) Fact Sheet

U.S. Department of Defense (DoD) Fact Sheet

The Biomedical Advanced Research and Development Authority (BARDA) Fact Sheet

The U.S. Food and Drug Administration (FDA) Fact Sheet

Healthier World, Safer America: A US government Roadmap for International Action to Prevent the Next Pandemic

On October  24, 2017, GHC member PATH released its new analysis on global health security: “Healthier World, Safer America: A US government Roadmap for International Action to Prevent the Next Pandemic.”  To protect the health of Americans and people abroad, US leadership to drive global health security is more important than ever. While laudable progress has been achieved, the work to reduce global health threats with pandemic potential has only just begun.

The paper aims to examine the benefits of investments in pandemic preparedness, as well as recommends the US Administration and Congress come together behind a comprehensive US strategy, robust investments, and continued vigilance both at home and abroad. The recommendations focus on global leadership, a US plan for international action, and research and development; underpinned by the risks of unsustainable funding, with special focus given to the Ebola supplemental funding sunset set to occur in FY2019. Read the report or coverage in The Atlantic to learn more.